Is Reddit a Buy on the Dip?
Reddit (NYSE:RDDT) share price has been on the proverbial ropes…
Sell
43
NMTC Quote, Financials, Valuation and Earnings
Last price:
$1.07
Seasonality move
:
-32.95%
Day range:
$1.01 - $1.09
52-week range:
$0.55 - $1.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.35x
P/B ratio:
11.36x
Volume:
86.6K
Avg. volume:
207K
1-year change:
0.93%
Market cap:
$33.3M
Revenue:
$3.5M
EPS (TTM):
-$0.26
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, NeuroOne Medical Technologies has 85.19% upside to fair value with a price target of -- per share.
NMTC vs. S&P 500
-
Over the past 5 trading days, NeuroOne Medical Technologies has overperformed the S&P 500 by 12.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
NeuroOne Medical Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
NeuroOne Medical Technologies has grown year-over-year revenues for 1 quarter straight. In the most recent quarter NeuroOne Medical Technologies reported revenues of $3.3M.
Earnings Growth
-
NeuroOne Medical Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter NeuroOne Medical Technologies reported earnings per share of $0.06.
Enterprise value:
32.2M
EV / Invested capital:
--
Price / LTM sales:
5.35x
EV / EBIT:
--
EV / Revenue:
5.60x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.7M
Return On Assets:
-128.38%
Net Income Margin (TTM):
-125.02%
Return On Equity:
-238.93%
Return On Invested Capital:
-238.93%
Operating Margin:
52.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $252K | $2.8M | $5.7M | $977.7K | $3.3M | |
| Gross Profit | -$70K | $735.1K | $2.7M | $266.3K | $1.9M | |
| Operating Income | -$9M | -$13.6M | -$6.8M | -$3.4M | $1.7M | |
| EBITDA | -$8.9M | -$13.2M | -$6.3M | -$3.3M | $2.2M | |
| Diluted EPS | -$0.56 | -$0.68 | -$0.26 | -$0.14 | $0.06 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.3M | $16.6M | $9M | $5.1M | $5.7M | |
| Total Assets | $7.9M | $17.2M | $9.7M | $5.8M | $6.5M | |
| Current Liabilities | $6.2M | $1.1M | $1.3M | $1.4M | $1.6M | |
| Total Liabilities | $6.5M | $1.2M | $1.5M | $1.4M | $3.6M | |
| Total Equity | $1.4M | $15.9M | $8.2M | $4.4M | $2.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$8.3M | -$13.2M | -$7M | -$3.8M | $208.1K | |
| Cash From Investing | -$3.2M | $2.6M | -$107.5K | -$37.1K | -$24.4K | |
| Cash From Financing | -$16K | $8.6M | $5.6M | $1.2M | -$509.3K | |
| Free Cash Flow | -$8.6M | -$13.6M | -$7.1M | -$3.8M | $183.6K | |
NMTC
Sector
Market Cap
$33.3M
$38.4M
Price % of 52-Week High
72%
45.53%
Dividend Yield
0%
0%
Shareholder Yield
-17.81%
-0.78%
1-Year Price Total Return
0.94%
-39.05%
Beta (5-Year)
0.659
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1.01
200-day SMA
Buy
Level
$0.90
Bollinger Bands (100)
Buy
Level
0.77 - 1.11
Chaikin Money Flow
Sell
Level
-14.3M
20-day SMA
Sell
Level
$1.09
Relative Strength Index (RSI14)
Buy
Level
52.89
ADX Line
Sell
Level
23.78
Williams %R
Neutral
Level
-27.1523
50-day SMA
Buy
Level
$1.07
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
28.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-21.7754)
Sell
CA Score
(Annual)
Level (-8.2423)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (13.4507)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Stock Forecast FAQ
In the current month, NMTC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NMTC average analyst price target in the past 3 months is --.
-
Where Will NeuroOne Medical Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that NeuroOne Medical Technologies share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About NeuroOne Medical Technologies?
Analysts are divided on their view about NeuroOne Medical Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NeuroOne Medical Technologies is a Sell and believe this share price will drop from its current level to --.
-
What Is NeuroOne Medical Technologies's Price Target?
The price target for NeuroOne Medical Technologies over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NMTC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for NeuroOne Medical Technologies is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NMTC?
You can purchase shares of NeuroOne Medical Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NeuroOne Medical Technologies shares.
-
What Is The NeuroOne Medical Technologies Share Price Today?
NeuroOne Medical Technologies was last trading at $1.07 per share. This represents the most recent stock quote for NeuroOne Medical Technologies. Yesterday, NeuroOne Medical Technologies closed at $1.08 per share.
-
How To Buy NeuroOne Medical Technologies Stock Online?
In order to purchase NeuroOne Medical Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Qualcomm Stock: 5G Leader at a Bargain Price?
Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…
What Is Buffett Buying and Selling Now?
In Q4 of last year, Warren Buffett made a few…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
59
GRRR alert for Mar 15
Gorilla Technology Group [GRRR] is up 29.72% over the past day.
Sell
49
SMTC alert for Mar 15
Semtech [SMTC] is up 21.28% over the past day.
Buy
62
PLPC alert for Mar 15
Preformed Line Products [PLPC] is up 17.38% over the past day.
